Health SystemSchool of MedicineMedical CenterMedical Group
UCDHS logo periodical
News in brief

$1 million more for prostate research

Researchers at the UC Davis Cancer Center this spring received three new grants totaling more than $1 million to study the genetics of prostate cancer.

Ralph deVere White, director of the UC Davis Cancer Center, received a three-year grant of $468,000 from the National Cancer Institute to study the functions of different p53 mutations in prostate cancer. P53 is a tumor suppresser gene that plays a key role in many cancers.

Christopher Evans, an assistant professor in the Department of Urology, received a two-year grant of $235,000 from the Department of Defense to study p53 mutations in archival prostate cancer tissue.

Paul Gumerlock, an assistant professor in the Division of Hematology/Oncology, received a two-year $425,000 grant from the Department of Defense to study protein interaction with the N-terminus of the androgen receptor.

Prostate cancer research at UC Davis receives $2.5 million of the more than $9 million earmarked for cancer research.

"These grants bolster the UC Davis Cancer Center's efforts to strengthen its work in basic research," said deVere White, a professor and chair of the Department of Urology. "They emphasize that we are joining the national effort to find better ways to detect, treat and ultimately cure cancer."


Home | Table of Contents | To our Readers | Building on Basics
Focusing on Patients | In Translation | First Steps
Campus Connection | Benefactors | News in Brief

UC Davis Health System | © 2000, 2001, 2002 UC Regents. All rights reserved.

Message to Editor
Supporting Cancer Center
UC Davis Cancer CenterUC Davis Health System

Larkin photo

Pathologist Edward Larkin discusses how flow cytometry can be used to diagnose hematologic malignancies. A professor in the medical school's pathology department, Larkin was one of more than a dozen presenters and more than 90 scientists who attended the program.